101 related articles for article (PubMed ID: 26748952)
1. Reversal of rocuronium-induced neuromuscular blockade by sugammadex allows for optimization of neural monitoring of the recurrent laryngeal nerve.
Lu IC; Wu CW; Chang PY; Chen HY; Tseng KY; Randolph GW; Cheng KI; Chiang FY
Laryngoscope; 2016 Apr; 126(4):1014-9. PubMed ID: 26748952
[TBL] [Abstract][Full Text] [Related]
2. Effect of quantitative versus qualitative neuromuscular blockade monitoring on rocuronium consumption in patients undergoing abdominal and gynecological surgery: a retrospective cohort study.
Blum LV; Steeger E; Iken S; Lotz G; Zinn S; Piekarski F; Zacharowski K; Raimann FJ
J Clin Monit Comput; 2023 Apr; 37(2):509-516. PubMed ID: 35986228
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Deep and Moderate Neuromuscular Blockade for Major Laparoscopic Surgery in Children: A Randomized Controlled Trial.
Wei G; Li YX; Chen Y; Diao M; Zhong JW; Pan SD
Paediatr Drugs; 2024 May; 26(3):347-353. PubMed ID: 38512578
[TBL] [Abstract][Full Text] [Related]
4. The influence of neuromuscular blockade on phase lag entropy and bispectral index: A randomized, controlled trial.
Jin S; Baik HJ; Cho S; Chung RK; Kong KA; Kim YJ
PLoS One; 2021; 16(9):e0257467. PubMed ID: 34520506
[TBL] [Abstract][Full Text] [Related]
5. Effects of sevoflurane and adenosine receptor antagonist on the sugammadex-induced recovery from rocuronium-induced neuromuscular blockade in rodent phrenic nerve-hemidiaphragm tissue specimens.
Kim YB; Choi JM; Park C; Choi HR; In J; Yang HS
Pharmacol Res Perspect; 2021 Aug; 9(4):e00827. PubMed ID: 34337892
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the molecular dynamics of sugammadex-rocuronium complexation: A blueprint for cyclodextrin drug design.
Anderson A; García-Fandiño R; Piñeiro Á; O'Connor MS
Carbohydr Polym; 2024 Jun; 334():122018. PubMed ID: 38553217
[TBL] [Abstract][Full Text] [Related]
7. Sugammadex dose in infants.
Cortínez LI; Anderson BJ
Paediatr Anaesth; 2024 Jan; 34(1):5-6. PubMed ID: 37807656
[No Abstract] [Full Text] [Related]
8. Use of sugammadex for neuromuscular blockade reversal on a dog with myasthenia gravis undergoing thymoma resection.
Araos J; Martin-Flores M
Vet Anaesth Analg; 2024; 51(3):310-312. PubMed ID: 38561309
[No Abstract] [Full Text] [Related]
9. Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study.
Krijtenburg P; de Boer A; Bash LD; Scheffer GJ; Keijzer C; Warlé MC
Perioper Med (Lond); 2024 Mar; 13(1):22. PubMed ID: 38539254
[TBL] [Abstract][Full Text] [Related]
10. The Influence of Electromyographic on Electroencephalogram-Based Monitoring: Putting the Forearm on the Forehead.
Lichtenfeld F; Kratzer S; Hinzmann D; García PS; Schneider G; Kreuzer M
Anesth Analg; 2024 Jun; 138(6):1285-1294. PubMed ID: 37756246
[TBL] [Abstract][Full Text] [Related]
11. Sugammadex: A Review of the Considerations for Women of Childbearing Age.
Hirsch JG; Chia PA; Jahr JS
Am J Ther; 2023 Mar-Apr 01; 30(2):e146-e150. PubMed ID: 36892560
[No Abstract] [Full Text] [Related]
12. Trapping and reversing neuromuscular blocking agent by anionic pillar[5]arenes: Understanding the structure-affinity-reversal effects.
Zhao Q; Zhu J; Chen Y; Dong H; Zhou S; Yin Y; Cai Q; Chen S; Chen C; Wang L
J Hazard Mater; 2024 May; 469():133875. PubMed ID: 38457970
[TBL] [Abstract][Full Text] [Related]
13. Improved Reliability of Electromyography-Based Neuromuscular Monitoring During Laparoscopic Surgery Achieved by the Modified Attachment Method for Nihon-Kohden NM-345Y™ Stimulating Electrodes: A Case Report.
Kaneko S; Makino M; Miyagawa K; Murata H; Hara T
Cureus; 2024 Feb; 16(2):e54024. PubMed ID: 38476816
[TBL] [Abstract][Full Text] [Related]
14. Effect of neuromuscular blockade reversal by pyridostigmine on spectral entropy values during recovery from desflurane anesthesia: a prospective, randomized, double-blind, controlled trial.
Kim E; Ryu JH; Byun SH
Korean J Anesthesiol; 2016 Jun; 69(3):227-33. PubMed ID: 27274366
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular monitoring: an update.
Duţu M; Ivaşcu R; Tudorache O; Morlova D; Stanca A; Negoiţă S; Corneci D
Rom J Anaesth Intensive Care; 2018 Apr; 25(1):55-60. PubMed ID: 29756064
[TBL] [Abstract][Full Text] [Related]
16. Tolerance to preoperative placement of electrodes for neuromuscular monitoring using the Tetragraph™.
Espinal LM; Kalsotra S; Rice-Weimer J; Kitio SAY; Tobias JD
Saudi J Anaesth; 2024; 18(2):205-210. PubMed ID: 38654867
[TBL] [Abstract][Full Text] [Related]
17. Machine learning based analysis and detection of trend outliers for electromyographic neuromuscular monitoring.
Verdonck M; Carvalho H; Fuchs-Buder T; Brull SJ; Poelaert J
J Clin Monit Comput; 2024 Apr; ():. PubMed ID: 38573367
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic simulation can detect erroneous TOF counts.
Obara S; Suhara R; Murakawa M
J Anesth; 2024 Jun; 38(3):414-416. PubMed ID: 38430259
[No Abstract] [Full Text] [Related]
19. Sugammadex approved to reverse NMBA effects.
Thompson CA
Am J Health Syst Pharm; 2016 Feb; 73(3):100. PubMed ID: 26796899
[No Abstract] [Full Text] [Related]
20. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
Kaufhold N; Schaller SJ; Stäuble CG; Baumüller E; Ulm K; Blobner M; Fink H
Br J Anaesth; 2016 Feb; 116(2):233-40. PubMed ID: 26787792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
